CXCL10 and Hypoglycemia: Molecules such as CXCL10 and IL-6 have been reported to be involved in abnormal glucose metabolism by inhibition of hepatic gluconeogenesis decreasing the concentration of glycemia in the blood [43–45], which may explain our result in patients with hypoglycemia.